GB0715047D0 - Novel Compounds - Google Patents

Novel Compounds

Info

Publication number
GB0715047D0
GB0715047D0 GBGB0715047.7A GB0715047A GB0715047D0 GB 0715047 D0 GB0715047 D0 GB 0715047D0 GB 0715047 A GB0715047 A GB 0715047A GB 0715047 D0 GB0715047 D0 GB 0715047D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0715047.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0715047.7A priority Critical patent/GB0715047D0/en
Publication of GB0715047D0 publication Critical patent/GB0715047D0/en
Priority to PCT/EP2008/060049 priority patent/WO2009016227A2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0715047.7A 2007-08-02 2007-08-02 Novel Compounds Ceased GB0715047D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0715047.7A GB0715047D0 (en) 2007-08-02 2007-08-02 Novel Compounds
PCT/EP2008/060049 WO2009016227A2 (en) 2007-08-02 2008-07-31 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0715047.7A GB0715047D0 (en) 2007-08-02 2007-08-02 Novel Compounds

Publications (1)

Publication Number Publication Date
GB0715047D0 true GB0715047D0 (en) 2007-09-12

Family

ID=38529161

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0715047.7A Ceased GB0715047D0 (en) 2007-08-02 2007-08-02 Novel Compounds

Country Status (2)

Country Link
GB (1) GB0715047D0 (en)
WO (1) WO2009016227A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6723930B2 (en) 2014-02-07 2020-07-15 エムティーエー タモガトット クタトクソポルトク イロダジャ Novel use of sigma-1-receptor agonist compounds
US10842794B2 (en) 2014-02-07 2020-11-24 Támogatott Kutatócsoportok Irodája Use of Sigma-1 receptor agonist compounds
ES2886045T3 (en) * 2017-04-11 2021-12-16 Ceva Sante Animale Sarpogrelate for use in a method for the treatment of heart disease in mammals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861409A (en) * 1995-05-19 1999-01-19 Eli Lilly And Company Tetrahydro-beta-carbolines
GB9819033D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds VI
GB0422263D0 (en) * 2004-10-07 2004-11-10 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
WO2009016227A2 (en) 2009-02-05
WO2009016227A3 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
GB0710528D0 (en) Novel compounds
EP2152081A4 (en) Novel compounds
GB0712888D0 (en) Novel compounds
EP2146745A4 (en) Novel compounds
GB0705882D0 (en) Novel compounds
GB0710865D0 (en) Novel compounds
GB0706630D0 (en) Novel compounds
GB0705803D0 (en) Novel compounds
GB0708858D0 (en) Novel compounds
GB0710863D0 (en) Novel compounds
GB0715047D0 (en) Novel Compounds
GB0711521D0 (en) Novel compounds
GB0712392D0 (en) Novel compounds
GB0703973D0 (en) Novel compounds
GB0712885D0 (en) Novel compounds
GB0700993D0 (en) Novel compounds
GB0703404D0 (en) Novel compounds
GB0703630D0 (en) Novel compounds
GB0703631D0 (en) Novel compounds
GB0703677D0 (en) Novel compounds
GB0703397D0 (en) Novel compounds
GB0712887D0 (en) Novel compounds
GB0712886D0 (en) Novel compounds
GB0704766D0 (en) Novel compounds
GB0712865D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)